MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Magnetic resonance characteristic of Parkinson’s disease based on the presence of cognitive impairment

F.B. Doniyorova (Tashkent, Uzbekistan)

Meeting: 2016 International Congress

Abstract Number: 183

Keywords: Cognitive dysfunction, Magnetic resonance imaging(MRI), Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To study the performance of MRI in patients with Parkinson’s disease, depending on the stage of the disease.

Background: Steadily progressive chronic neurodegenerative disease of the central nervous system – Parkinson’s disease (PD) – has traditionally been seen as pathology predominantly affects the motor or motor area.

Methods: Using magnetic resonance imaging were examined 49 patients with Parkinson’s disease. Stage of disease as determined by a scale Hyun and Yara, was represented in this group of patients as follows: Stage 1 – 12 people, 2,0 stage – 13 people, 2,5 stage – 16 people, 3,0 Step – 8 people. In seven patients from this group were diagnosed with dementia. With the development of the disease was marked deterioration of the general condition of the cognitive functions, which in some cases has reached the level of dementia. On the 2 stages of the disease pattern changes significantly. Cognitive impairment is detected only in 24% of subjects, mild cognitive impairment was found in 72%. 4% of patients on two stages of the disease in accordance with ICD-10, was diagnosed with dementia. At the third stage of the disease dementia it was established in 57% of cases, and the lack of cognitive impairment was detected in 14% of subjects.

Results: Analysis of the data revealed that significant (p <0.01) were found differences in the position of atrophic changes between a group of patients diagnosed with dementia and patients, the clinical picture of the disease which has been complicated by dementia. In patients with dementia there was a relatively high degree of atrophy in the temporal and occipital lobes relative to patients without dementia. Three of the seven patients with dementia marked by moderate, and one – severe degree of atrophy in the frontal, parietal-temporal areas of the brain hemispheres. Patients with dementia and atrophy in the temporal, occipital and frontal lobes of the brain with the help of experimental psychological studies have revealed a violation of memory, reduced visual-spatial perception, increasing the number of proofreading errors in the performance of the sample and Kraepelin table, brief assessment scale mental status.

Conclusions: Thus, the results suggest an increase in the role of cortical structures in the development of cognitive impairment in the later stages of Parkinson’s disease.

To cite this abstract in AMA style:

F.B. Doniyorova. Magnetic resonance characteristic of Parkinson’s disease based on the presence of cognitive impairment [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/magnetic-resonance-characteristic-of-parkinsons-disease-based-on-the-presence-of-cognitive-impairment/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/magnetic-resonance-characteristic-of-parkinsons-disease-based-on-the-presence-of-cognitive-impairment/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley